• Flanders Investment & Trade
  • Team Vesalius

A KU Leuven graduate in biology and virology, Johan Neyts is now a full professor there, teaching virology to medical and dental students.

Johan Neyts

KU Leuven

Rega instituut KU Leuven
Oude Markt 13 - bus 5500
3000 Leuven

Neyts is also affiliated with the Leuven Rega Institute for Medical Research, where he is involved in the development of a promising vaccine for COVID-19. For his work on anti-viral drugs, he is also been engaged by the Bill & Melinda Gates Foundation and many large pharmaceutical companies. Neyts has authored about 400 scientific articles, contributing to the fight against herpes, yellow fever, rabies, zika virus, AIDS and hepatitis B, among others.

Team Vesalius visionairies

Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare

Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?